TG/HDL-C Ratio as a Superior Diagnostic Biomarker for Coronary Plaque Burden in First-Time Acute Coronary Syndrome

Fatih Aydin1, Bektaş Murat1, Selda Murat2

  • 1Department of Cardiology, Eskisehir City Hospital, 26080 Eskisehir, Türkiye.

PubMed

Insights

The TG/HDL-C ratio is a better predictor of coronary plaque burden than LDL-C in acute coronary syndrome patients. This lipid ratio offers a cost-effective tool for assessing plaque extent during initial evaluations.

Area of Science:

  • Cardiology
  • Lipidology
  • Diagnostic Biomarkers

Background:

  • Current acute coronary syndrome (ACS) risk assessment relies heavily on LDL-C, but its accuracy in reflecting coronary plaque burden is limited.
  • Investigating advanced lipid profiles, particularly the TG/HDL-C ratio, may offer improved diagnostic capabilities for significant coronary plaque in treatment-naïve ACS patients.

Purpose of the Study:

  • To evaluate the TG/HDL-C ratio as a diagnostic marker for coronary plaque burden in first-time ACS patients.
  • To compare the efficacy of the TG/HDL-C ratio against LDL-C in predicting extensive coronary plaque.

Main Methods:

  • Analysis of 376 treatment-naïve ACS patients undergoing PCI with complete lipid data.
  • Quantification of coronary plaque burden using quantitative coronary angiography (QCA) and stratification by lesion count.
  • Measurement of lipid levels and ratios (LDL-C, HDL-C, TC, TG, LDL/HDL-C, TC/HDL-C, TG/HDL-C) with statistical analysis including logistic regression and ROC analysis.

Main Results:

  • The TG/HDL-C ratio demonstrated a significant progressive increase with higher coronary plaque burden (lesion count).
  • The TG/HDL-C ratio was identified as an independent predictor of high plaque burden (OR 1.25, p=0.004), outperforming LDL-C.
  • ROC analysis indicated the superior diagnostic performance of the TG/HDL-C ratio.

Conclusions:

  • The TG/HDL-C ratio serves as a more effective diagnostic biomarker than LDL-C for identifying extensive coronary plaque burden in ACS patients.
  • Incorporating the TG/HDL-C ratio into initial lipid profiling provides a valuable, cost-effective tool for risk stratification.

Related Concept Videos

Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
218
Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT01:25

Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT

Calcium-Scoring CT ScanA calcium-scoring CT scan, also known as coronary artery calcium (CAC) scan, detects calcium deposits in the coronary arteries. This test assesses the risk of coronary artery disease (CAD), which can lead to cardiovascular events such as angina, heart failure, and sudden cardiac arrest.A calcium-scoring CT scan is generally recommended for individuals at intermediate risk of CAD without symptoms. It includes:Men aged 40-75 and women aged 50-75: Especially those with a...
399
Hazard Ratio01:12

Hazard Ratio

The hazard ratio (HR) is a widely used measure in clinical trials to compare the risk of events, such as death or disease recurrence, between two groups over time. It reflects the ratio of hazard rates—the instantaneous risk of the event occurring—between a treatment group and a control group. This measure provides valuable insights into the relative effectiveness of a treatment by assessing how the risk of an event differs between the two groups.
For example, in a clinical trial...
561
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
541
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
890
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
590